论文部分内容阅读
目的观察阿昔洛韦与病毒唑联合治疗儿童病毒性脑膜炎的的效果。方法将我院及梅州市人民医院136例病毒性脑膜炎患儿随机分为治疗组及对照组,对照组患者服用阿昔洛韦,治疗组患者在对照组基础上加服病毒唑。结果治疗组总有效率为90.6%,显著高于对照组的67.2%,差异有统计学意义(p<0.05)。结论采用阿昔洛韦与病毒唑联合治疗儿童病毒性脑膜炎,可有效对儿童大脑进行保护,尽快控制病情,最大限度减少并发症,且毒副作用少,安全性可靠,值得推广应用。
Objective To observe the effect of acyclovir and ribavirin in the treatment of viral viral meningitis in children. Methods 136 cases of viral meningitis in our hospital and Meizhou People’s Hospital were randomly divided into treatment group and control group. Patients in the control group took acyclovir. The patients in the treatment group received ribavirin on the basis of the control group. Results The total effective rate was 90.6% in the treatment group, which was significantly higher than 67.2% in the control group, the difference was statistically significant (p <0.05). Conclusion The combination of acyclovir and ribavirin in the treatment of viral meningitis in children can effectively protect the brain of children, control the disease as soon as possible, minimize the complications, reduce the side effects and have safety and reliability, which is worth popularizing and applying.